Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions

被引:31
作者
Wells, JW [1 ]
Darling, D [1 ]
Farzaneh, F [1 ]
Galea-Lauri, J [1 ]
机构
[1] Kings Coll London, GKT Sch Med, Rayne Inst, Dept Haematol & Mol Med, London SE5 9NU, England
关键词
D O I
10.1111/j.1365-3083.2005.01556.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine bone marrow-derived dendritic cells (DC) can be generated by culture in the presence of granulocyte/macrophage colony-stimulating factor (GM-CSF) alone or GM-CSF in conjunction with interleukin-4 (IL-4). However, these two culture methods result in the production of heterogeneous DC populations with distinct phenotypic and stimulatory properties. In this study, we investigated the properties of DC generated under serum-free conditions in the presence or absence of IL-4 and compared their yield and phenotype to that of DC generated in the presence of fetal calf serum (FCS) ( IL-4). We did not observe a significant difference in the total cell yield between these four culture conditions, although the proportion of CD11c(+) DC in cultures that received FCS was higher than that of their counterparts generated under serum-free conditions. Also, the four culture conditions generated CD11c(+) DC with comparable levels of major histocompatibility complex (MHC) class II, CD40, CD80 and CD86 expression, with the exception of cells cultured under serum-free conditions in the absence of IL-4, which displayed suboptimal levels of these markers. Moreover, we compared the functional and stimulatory properties of DC generated under serum-free conditions in the presence or absence of IL-4. DC cultured in the presence of IL-4 were stronger stimulators of allogeneic splenocytes in a primary mixed lymphocyte reaction (MLR) and of naive antigen-specific OT-II transgenic T cells when pulsed with the class II ovalbumin (OVA)(323-339) peptide or whole OVA protein than DC cultured in the absence of IL-4. However, both DC populations displayed a similar capacity to take up fluorescein isothiocyanate (FITC)-albumin by macropinocytosis and FITC-Dextran by the mannose receptor and to secrete IL-12 in response to stimulation with lipopolysaccharide (LPS) or an agonistic anti-CD40 monoclonal antibody. Therefore, we conclude that although both DC culture methods result in the production of DC with similar functional abilities, under serum-free conditions, DC cultured in GM-CSF and IL-4 show an increased stimulatory potential over DC cultured in GM-CSF alone. This is an important consideration in the design of experiments where DC are being exploited as immunotherapeutic vaccines.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 36 条
[1]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[2]   Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[3]  
Buchele S, 1997, ADV EXP MED BIOL, V417, P233
[4]   Origin, maturation and antigen presenting function of dendritic cells [J].
Cella, M ;
Sallusto, F ;
Lanzavecchia, A .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :10-16
[5]   Priming to mycobacterial antigen in vivo using antigen-pulsed antigen presenting cells generated in vitro is influenced by the dose and presence of IL-4 in APC cultures [J].
Dillon, SM ;
Hart, DNJ ;
Abernethy, N ;
Watson, JD ;
Baird, MA .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (01) :1-9
[6]   Production of IL-12 by human monocyte-derived dendritic cells is optimal when the stimulus is given at the onset of maturation, and is further enhanced by IL-4 [J].
Ebner, S ;
Ratzinger, G ;
Krösbacher, B ;
Schmuth, M ;
Weiss, A ;
Reider, D ;
Kroczek, RA ;
Herold, M ;
Heufler, C ;
Fritsch, P ;
Romani, N .
JOURNAL OF IMMUNOLOGY, 2001, 166 (01) :633-641
[7]  
Eggert AO, 2002, EUR J IMMUNOL, V32, P122, DOI 10.1002/1521-4141(200201)32:1<122::AID-IMMU122>3.0.CO
[8]  
2-C
[9]   Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains [J].
Feili-Hariri, M ;
Morel, PA .
CLINICAL IMMUNOLOGY, 2001, 98 (01) :133-142
[10]   Immunotherapy of NOD mice with bone marrow-derived dendritic cells [J].
Feili-Hariri, M ;
Dong, X ;
Alber, SM ;
Watkins, SC ;
Salter, RD ;
Morel, PA .
DIABETES, 1999, 48 (12) :2300-2308